These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6115611)

  • 1. alpha-Halogenmethyl carbonyl compounds as very potent inhibitors of factor XIIIa in vitro.
    Reinhardt G
    Ann N Y Acad Sci; 1981; 370():836-42. PubMed ID: 6115611
    [No Abstract]   [Full Text] [Related]  

  • 2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of crosslinking by factor XIIIa on the migration of vascular smooth muscle cells into fibrin gels.
    Naito M; Nomura H; Iguchi A; Thompson WD; Smith EB
    Thromb Res; 1998 May; 90(3):111-6. PubMed ID: 9684729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIIIa-catalyzed coupling of structural proteins.
    Kahn DR; Cohen I
    Biochim Biophys Acta; 1981 May; 668(3):490-4. PubMed ID: 6113010
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
    Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
    Kusch M; Grundmann C; Keitel S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):575-80. PubMed ID: 16988554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet factor XIIIa-catalyzed reactions by calmodulin.
    Cohen I; Kahn DR; Drisdel RC
    Biochim Biophys Acta; 1986 Sep; 883(2):265-70. PubMed ID: 2874832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 13. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines.
    Mosher DF; Schad PE; Kleinman HK
    J Supramol Struct; 1979; 11(2):227-35. PubMed ID: 548650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of fibronectin--fibrin cross-linking.
    Mosher DF; Johnson RB
    Ann N Y Acad Sci; 1983 Jun; 408():583-94. PubMed ID: 6135382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitronectin is a substrate for transglutaminases.
    Sane DC; Moser TL; Pippen AM; Parker CJ; Achyuthan KE; Greenberg CS
    Biochem Biophys Res Commun; 1988 Nov; 157(1):115-20. PubMed ID: 2461707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
    Schense JC; Hubbell JA
    Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.
    Leung-Toung R; Tam TF; Wodzinska JM; Zhao Y; Lowrie J; Simpson CD; Karimian K; Spino M
    J Med Chem; 2005 Apr; 48(7):2266-9. PubMed ID: 15801818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cDNA coding for human factor XIIIa.
    Grundmann U; Amann E; Zettlmeissl G; Küpper HA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8024-8. PubMed ID: 2877457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen).
    Greenberg CS; Enghild JJ; Mary A; Dobson JV; Achyuthan KE
    Biochem J; 1988 Dec; 256(3):1013-9. PubMed ID: 3066350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.